Ovarian cancer in a woman previously diagnosed with endometriosis and an extremely high serum CA-125 level

Clinical and Experimental Obstetrics and Gynecology

Volumn 28, Issue 2, 2001, Pages 83-85

  Check, J H ^a   Check, M L ^a   Kiefer, D ^a   Aikins J , Jr ^a  

^a NONE   (United States)

Author keywords

CA 125; Clear cell carcinoma; Endometriosis; Ovary

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CLEAR CELL CARCINOMA; DISEASE MARKER; ENDOMETRIOSIS; FATALITY; FEMALE; FOLLOW UP; HUMAN; METASTASIS; OVARIECTOMY; OVARY CANCER; PELVIS TUMOR;

ADENOCARCINOMA, CLEAR CELL; ADULT; CA-125 ANTIGEN; ENDOMETRIOSIS; FATAL OUTCOME; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 0034911777     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Extreme elevation of serum CA-125 in two women with severe endometriosis: Case report
2. A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer
3. Ovarian cancer antigen CA-125: A prospective clinical assessment of its role as a tumor marker
4. Preoperative serum tumor-associated antigen levels in women with pelvic masses
5. CA-125 antigen levels in obstetric and gynecologic patients
6. Elevated serum concentrations of CA-125 in patients with advanced endometriosis
7. Serum levels of CA-125 in patients with endometriosis. A preliminary report
8. The effect of hysterectomy on serum CA-125 levels in patients with adenomyosis and uterine fibroids
9. Expression of CA-125 in adenomyosis
10. CA-125 in women with endometriosis
11. CA-125 levels measured in different phases of the menstrual cycle in screening for endometriosis
12. CA-125 levels in endometriosis
13. CA-125 in an effective marker for patients with external endometriosis and on danazol: Case reports
14. Serum and peritoneal lavage fluid CA-125 levels in endometriosis
15. Serum CA-125 in women with endometriosis and chronic pelvic pain
16. Endometriosis causing very high early first trimester serum CA-125 levels
17. Benign gynecologic conditions associated with a CA-125 level & gt; 1,000 U/mL. A case report
18. Serum CA-125 measurements > 65 U/mL. Clinical value
19. Drastic elevation of serum CA-125, CA-72-4 and CA-19-9 levels during menses in a patient with probable endometriosis
20. Explosive rise of serum CA-125 following the rupture of ovarian endometrioma
21. Extremely elevated serum CA-125 due to endometriosis
22. Abnormally high values of CA-125 and CA-19-9 in women with benign tumors
23. Malignant changes in endometriosis
24. Prevalence of ovarian endometriosis in epithelial ovarian cancer
25. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage
26. Endometrioid carcinoma of the ovary: Retrospective review of 145 cases
27. Malignant neoplasms arising in endometriosis
28. Cancer risk after a hospital discharge diagnosis of endometriosis
29. Endometriosis and ovarian cancer
30. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53
31. Prevalence of endometriosis in ovarian cancer
32. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ
33. Ovarian atypical endometriosis: Its close association with malignant epithelial tumours
34. The development of malignancy in endometriosis
35. Carcinoma of the ovary and endometriosis
36. Endometrioid and clear cell carcinoma of the ovary
37. The pathological assessment of ovarian neoplasms: I. Introduction to the common 'epithelial' tumours and analysis of benign 'epithelial' tumours
38. Endometrioid and clear cell carcinoma of the ovary
39. Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
40. Endometrioid carcinoma of the ovary and endometriosis
41. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis
42. Histologic transformation of benign endometriosis to early epithelial ovarian cancer
43. Clear cell adenocarcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease
44. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: Clinicopathologic evaluation